Allocetra™, the drug in question, is specifically designed for the treatment of patients with peritoneal cancer – cancer of the membrane lining much of the abdomen.
Allocetra™, the drug in question, is specifically designed for the treatment of patients with peritoneal cancer – cancer of the membrane lining much of the abdomen.